ClinicalTrials.Veeva

Menu

Therapeutic Impacts of Theta Burst Stimulation Over Bilateral Posterior Superior Temporal Sulcus in Autism Spectrum Disorder

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Active, not recruiting

Conditions

Autism Spectrum Disorder

Treatments

Device: intermittent theta burst stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05578209
202102232A0

Details and patient eligibility

About

The investigator would like to investigate the impact of intermittent theta burst stimulation over bilateral posterior superior temporal sulcus in autism spectrum disorder

Enrollment

60 estimated patients

Sex

All

Ages

8 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Autism spectrum disorder, confirmed by Autism Diagnostic Observation Schedule II (CSS≧6)
  • No change in psychiatric drugs within one month

Exclusion criteria

  • Previous or current severe neurological disorder such as epilepsy, visual or hearing impairment
  • Previous or current severe systemic disease such as cardiovascular disease, diabetes or infection
  • Previous or current severe brain injury
  • Implementation of metal materials such as pacemaker or medication pump
  • Previous or current severe psychiatric disorders such as schizophrenia, bipolar disorder or substance abuse
  • Pregnancy
  • Individuals with a significant brain abnormality such as intracranial space occupied lesions
  • History of brain surgery or nervous system infection, such as meningitis and encephalitis
  • Previous febrile seizures
  • Concurrent use of medications which increased the risk of seizure attack.
  • Participate another clinical trial within one month.
  • Unable to complete MRI scan (claustrophobia)
  • Skin trauma on application site
  • Individuals with a large ischemic scar
  • Individuals suffering from multiple sclerosis
  • Individuals suffering from sleep deprivation during rTMS procedures
  • Individuals with a heavy consumption of alcohol
  • Individuals with a migraine headache from increased intracranial pressure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Active
Experimental group
Description:
Participants received the intervention of iTBS (The total pulse of every session is 1200 pulses) over bilateral posterior superior temporal sulcus for 4 weeks (5 days/week). \*iTBS = intermittent theta burst stimulation
Treatment:
Device: intermittent theta burst stimulation
Sham
Sham Comparator group
Description:
Participants received the sham intervention of iTBS (sham-coil) over bilateral posterior superior temporal sulcus for 4 weeks (5 days/week).
Treatment:
Device: intermittent theta burst stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Hsing-Chang Ni, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems